Sponsor GapSummit 2019

An unparalleled opportunity to showcase your organization to an international audience of biotech leaders and to connect with the next generation of leaders

GapSummit is made possible by the generous support of our sponsors. GapSummit 2019 offers sponsors a global platform to present their brand alongside the biggest change-makers in biotechnology, contribute to the conference program, as well as the opportunity to challenge and inspire 100 of the top Leaders of Tomorrow from around the world selected to attend.

For more information on sponsorship opportunities and to receive a sponsorship prospectus, contact GapSummit 2019 President, Mohamad Najia

Gold Sponsors


At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.

We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.


Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.

Bronze Sponsors


MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines . MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal & Metabolic Diseases, and Infection and Vaccines.

Johnson & Johnson Innovation

Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical devices and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation – JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs for patients. For more information please visit:


Pfizer colleagues take pride and satisfaction in contributing to one of the greatest human endeavors – innovating to bring therapies to patients that significantly improve their lives. At Kendall Square, one of Pfizer’s largest worldwide research and development hubs, scientists are working to discover and develop transformative medicines for a spectrum of needs, including rare diseases, atopic dermatitis, rheumatoid arthritis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), inflammatory bowel disease, muscular dystrophy, and alopecia. Colleagues thrive in an environment of shared trust, diversity of experience, and a passion for excellence. We are proud to be part of a global community within Pfizer and beyond, collaborating with the best minds in the field to explore what’s possible and extend our positive impact to people around the world.


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit and follow us on

Bill & Melinda Gates Medical Research Institute

The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Based in Cambridge, our mission is to develop products to fight malaria, tuberculosis, diarrheal diseases and serious maternal and child health disorders — major causes of mortality, poverty, and inequality in low- and middle-income countries. With unprecedented scientific tools at our disposal, now is the time to use them to save the lives of the world’s poorest people. Our focus is translational medicine: advancing novel drug and vaccine candidates from the laboratory to human studies. Funneling many possible ideas into a few viable solutions is the most challenging stage of the research and development process, and we embrace this challenge.

Knowledge Partner

McKinsey & Company

McKinsey & Company is one of the world’s leading management consulting firms. For over 90 years, we have helped our clients achieve substantial, lasting improvements in their performance, including in the healthcare sector. McKinsey brings a global 360° perspective across all stakeholders and an understanding of how healthcare really works. We have the experience and scale to provide real expertise across the system.

Globally, our Pharmaceuticals & Medical Products Practice includes more than 1,600 consultants, over 150 doctors with patient care or research experience, and at least 250 consultants with Master’s or doctoral degrees in the life sciences and medical fields. In addition, to fully capture opportunities, we can draw on more than 1000 advanced analytics experts and data scientists, 250 world class innovators and designers and over 2300 digital consultants developers.


The Broad Institute of MIT and Harvard

The Broad Institute of MIT and Harvard was launched in 2004 to improve human health by using genomics to advance our understanding of the biology and treatment of human disease, and to help lay the groundwork for a new generation of therapies.

The institute was founded to seize the opportunity that arose from the Human Genome Project — the international effort that successfully deciphered the entire human genetic code. Despite that accomplishment, scientists knew they still lacked a clear understanding of the genetic basis of disease, and how to translate that understanding into more effective prevention, diagnosis, and treatment.

The Broad Institute is an “experiment” in this new way of doing science. It spans some of Boston’s leading institutions (Harvard, MIT, and Harvard-affiliated hospitals) and scientific disciplines (biology, chemistry, medicine, computer science, and engineering). Today, the Broad community includes more than three thousand scientists, committed to advancing research in areas including infectious disease, cancer, psychiatric research, and cardiovascular disease.

Massachusetts Institute of Technology

MIT is driven by a shared purpose: to make a better world through education, research, and innovation. We are fun and quirky, elite but not elitist, inventive and artistic, obsessed with numbers, and welcoming to talented people regardless of where they come from.

Founded to accelerate the nation’s industrial revolution, MIT is profoundly American. With ingenuity and drive, our graduates have invented fundamental technologies, launched new industries, and created millions of American jobs. At the same time, and without the slightest sense of contradiction, MIT is profoundly global. Our community gains tremendous strength as a magnet for talent from around the world. Through teaching, research, and innovation, MIT’s exceptional community pursues its mission of service to the nation and the world.

Young European Biologists

Young European Biologists (YEB) is a non-profit student-run organisation for young scientists in the field of biology and biotechnology who are either studying or looking to study in Europe. Our aim is to improve the communication between universities from different countries and connect students to opportunities, by establishing our organization as the link between them. We strive to create a wide network promoting the exchange of ideas between young biologists across Europe and beyond.